Cargando…
My Experience with SARS-CoV-2, with a Focus on Testing
Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) got off to a slow start in the United States. In this commentary, I describe my experience with CoV disease 2019 (COVID-19), with a focus on being tested at the University of North Carolina—Chapel Hill Respiratory Diagnostic Ce...
Autor principal: | Cotter, Peggy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383536/ https://www.ncbi.nlm.nih.gov/pubmed/32703893 http://dx.doi.org/10.1128/JCM.01228-20 |
Ejemplares similares
-
The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
por: Greninger, Alexander L., et al.
Publicado: (2020) -
The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020) -
Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020) -
RT-qPCR Testing of SARS-CoV-2: A Primer
por: Bustin, Stephen A., et al.
Publicado: (2020) -
Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)